Cmin (story continued) [NCA / SHAM]

posted by Marcel – 2011-09-16 10:01 (5026 d 09:27 ago) – Posting: # 7355
Views: 8,648

Geia sou, Helmut!

Thanks for the feedback. I think a lot of people are having problem with Cmin because of some of the reasons you mention and because some/most people don't power their studies to Cmin, but to Cmax and occasionally AUC.

At what point do you think the increase in sample size becomes unethical?

Do you have a good reference article that shows that Clast is considered unreliable? By Clast, you mean the sample taken ~5 minutes prior to dosing, right?

Problems will continue to arise with steady state studies until this new draft guideline is released.

Take care,
Marcel

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,674 registered users;
39 visitors (0 registered, 39 guests [including 8 identified bots]).
Forum time: 19:29 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5